Day & Ennis’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$318K Sell
5,896
-443
-7% -$21.6K 0.11% 93
2023
Q3
$307K Sell
6,339
-90
-1% -$4.79K 0.11% 93
2023
Q2
$363K Sell
6,429
-2,320
-27% -$128K 0.14% 84
2023
Q1
$472K Sell
8,749
-1,579
-15% -$84.1K 0.18% 82
2022
Q4
$543K Sell
10,328
-589
-5% -$29.9K 0.21% 76
2022
Q3
$515K Sell
10,917
-1,143
-9% -$59.3K 0.21% 66
2022
Q2
$608K Sell
12,060
-366
-3% -$19.9K 0.23% 66
2022
Q1
$757K Sell
12,426
-3,430
-22% -$204K 0.25% 58
2021
Q4
$1.04M Sell
15,856
-19,165
-55% -$1.23M 0.34% 50
2021
Q3
$2.2M Sell
35,021
-1,255
-3% -$80.1K 0.76% 40
2021
Q2
$2.18M Sell
36,276
-48,612
-57% -$2.81M 0.76% 41
2021
Q1
$4.67M Buy
84,888
+8,310
+11% +$461K 1.77% 20
2020
Q4
$4.18M Buy
76,578
+2,886
+4% +$151K 1.66% 20
2020
Q3
$3.68M Buy
73,692
+37,632
+104% +$1.82M 1.6% 21
2020
Q2
$1.59M Buy
+36,060
New +$1.54M 0.79% 42

Other funds holding IHI

Day & Ennis's IHI Position: Q4 2023 in Review

Day & Ennis reduced its iShares US Medical Devices ETF (IHI) stake by 7% in Q4 2023, selling an estimated $21.6K and leaving 5,896 shares worth $318K. The position accounts for 0.11% of the portfolio, ranked #93.

Day & Ennis first reported a position in IHI in Q2 2020 and has held it in 15 quarters since. The position peaked at $4.67M in Q1 2021. 574 funds tracked by Wall St. Rank hold IHI as of Q4 2023.

  • Day & Ennis held 5,896 shares of iShares US Medical Devices ETF worth $318K as of Q4 2023.
  • Day & Ennis sold 443 iShares US Medical Devices ETF shares in Q4 2023, an estimated $21.6K.
  • iShares US Medical Devices ETF made up 0.11% of Day & Ennis's portfolio in Q4 2023, its #93 holding.
  • Day & Ennis first reported a position in iShares US Medical Devices ETF in Q2 2020 and has held it in 15 quarters since.
  • Day & Ennis's iShares US Medical Devices ETF position peaked at $4.67M in Q1 2021.
  • 574 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2023.

Based on Day & Ennis's 13F filing for Q4 2023, filed 18 Jan 2024.